PPAP2023-04-012023-06-30 PPAP2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member PPAP2023-06-30 PPAP2023-04-012023-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 532934 PPAP NOTLISTED PPAP Automotive Limited Equity 2023-04-01 2024-03-31 2023-08-12 2023-08-03 INR Lakhs First quarter 11:45:00 16:30:00 2023-08-12 2023-08-12 Not applicable Single segment Manufacturing of automotive components 2023-04-01 2023-06-30 Unaudited Standalone 1113636000.00 13106000.00 1126742000.00 705063000.00 0.00 -35300000.00 203681000.00 31721000.00 77204000.00 166370000.00 1148739000.00 -21997000.00 0.00 -21997000.00 0.00 -5805000.00 -5805000.00 0.00 -16192000.00 0.00 0.00 0.00 0.00 -16192000.00 -302000.00 -16494000.00 0.00 0.00 140000000.00 10 -1.16 -1.16 0.00 0.00 -1.16 -1.16 The above financial results have been prepared in accordance with Indian Accounting Standards ( Ind AS ) notified under Section 133 of the Companies Act, 2013, read together with the Companies (Indian Accounting Standards) Rules, 2015 (as amended). The above financial results have been reviewed by the Audit Committee in its meeting held on 12 August, 2023 and then approved by the Board of Directors in its meeting held on 12 August, 2023. The limited review, as required under Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 has been completed by the Statutory Auditors for the quarter ended 30 June, 2023 and they have expressed an unmodified opinion on the aforesaid results. The Company is primarily engaged in the business of manufacturing of automotive components, development and sale of plastic injection molds and development and sale of components for consumer goods. In the context of Ind AS - 108 Operating Segment , automotive component is the only reportable operating segment. The figures of quarter ended 31 March, 2023 are the balancing figures between the audited figures in respect of full financial year and the published figures of nine months ended 31% December, 2022 respectively, which were subject to limited review by the Statutory Auditors. The figures have been re-grouped / re-arranged wherever required for the purpose of comparison. Other Expenses 166370000.00 Gain /(Loss) on defined benefit obligation -1024000.00 -1024000.00 -722000.00 0.00